CA
NZ
UK
AU
IND
US
A group of ARCH Venture-affiliated entities and individuals filed a Schedule 13D with the SEC on November 9, 2026, disclosing a combined beneficial ownership position in Aspen Neuroscience, Inc. common stock as of a triggering event dated November 2, 2026.
Director Glenn Lurie of Avis Budget Group, Inc. filed a Form 4 on November 9, 2026, disclosing three separate sales of common stock totaling 6,101 shares on November 6, 2026.
Director Lynn Krominga of Avis Budget Group, Inc. filed a Form 4 on November 9, 2026, disclosing the sale of a combined 28,404 shares of common stock on November 6, 2026, at weighted average prices of $120.14 and $121.25 per share.
Director Lynda Scearcy of Sierra Bancorp filed a Form 4 on November 9, 2026, reporting two open-market sales of common stock totaling 18,025 shares executed on November 6 and November 9, 2026.
Aaron P. Graft, President and CEO of Triumph Financial, Inc. (NYSE:TFIN), filed a Form 4 on November 9, 2026, disclosing a series of transactions in the company's common stock between November 5 and November 9, 2026.
Langley Steinert, Executive Chair, Director, and 10% Owner of CarGurus, Inc. (NASDAQ:CARG), filed a Form 4 on November 9, 2026, disclosing four sales of Class A Common Stock executed on November 6, 2026, pursuant to a Rule 10b5-1 trading plan.
BeOne Medicines Ltd. SVP and General Counsel Lee Chan Henry filed a Form 4 on November 9, 2026, disclosing the sale of American Depositary Shares on November 5, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.
A Form 4 filed on November 9, 2026, with the SEC disclosed that Robyn Tannenbaum, President and CIO of Advanced Flower Capital Inc. (NASDAQ:AFCG), purchased 10,000 shares of common stock on November 6, 2026, at a weighted average price of $3.09 per share.
Brandon Hetzel, CFO and Treasurer of Advanced Flower Capital Inc., filed a Form 4 on November 9, 2026, disclosing a purchase of 1,500 shares of common stock on November 6, 2026.
Leonard M. Tannenbaum, a director and 10% owner of Advanced Flower Capital Inc., filed a Form 4 on November 9, 2026, disclosing a purchase of 18,500 shares of common stock on November 6, 2026.
Please wait processing your request...